Neuroimaging of Dementia with Lewy Bodies

Neuroimaging Clinics of North America

Volumn 22, Issue 1, 2012, Pages 67-81

  Taylor, John Paul ^a   O'Brien, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Dementia with Lewy bodies; Differential diagnosis; Neuroimaging

Indexed keywords

AMYLOID PROTEIN; DOPAMINE; FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODINE 2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL) N (3 FLUOROPROPYL)NORTROPANE I 123; IOFETAMINE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN DAMAGE; BRAIN METABOLISM; BRAIN PERFUSION; CARDIAC IMAGING; CHOLINERGIC SYSTEM; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; DOPAMINERGIC SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE ANALYSIS; MOLECULAR IMAGING; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VOXEL BASED MORPHOMETRY; WHITE MATTER;

BRAIN; HUMANS; LEWY BODY DISEASE; MAGNETIC RESONANCE IMAGING; NEUROIMAGING;

EID: 84856255150     PISSN: 10525149     EISSN: 15579867     Source Type: Journal    
DOI: 10.1016/j.nic.2011.11.001     Document Type: Review

References (103)

1. Lewy F.H. Paralyis Agitans: I. Pathologische Anatomie. Handbuch der Neurologie 1912, vol. 3:920-933. Julius Springer, Berlin. M. Lewandowsky (Ed.).
2. Okazaki H., Lipton L.S., Aronson S.M. Diffuse intracytoplasmatic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. JNeuropathol Exp Neurol 1961, 20:237-244.
3. Dickson D.W., Davies P., Mayeux R., et al. Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathol 1987, 75(1):8-15.
4. Byrne E.J., Lowe J., Godwin-Austen R.B., et al. Dementia and Parkinson's disease associated with diffuse cortical Lewy bodies. Lancet 1987, 1(8531):501.
5. Hansen L., Salmon D., Galasko D., et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990, 40(1):1-8.
6. Perry R.H., Irving D., Blessed G., et al. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. JNeurol Sci 1990, 95(2):119-139.
7. Gibb W.R., Esiri M.M., Lees A.J. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1987, 110(Pt 5):1131-1153.
8. Schulz-Schaeffer W. The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol 2010, 120(2):131-143.
9. Kramer M.L., Schulz-Schaeffer W.J. Presynaptic {alpha}-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies. JNeurosci 2007, 27(6):1405-1410.
10. McKeith I.G., Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996, 47(5):1113-1124.
11. McKeith I.G., Dickson D.W., Lowe J., et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology 2005, 65:1863-1872.
12. Emre M., Aarsland D., Brown R., et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007, 22(12):1689-1707.
13. Aarsland D., Ballard C.G., Halliday G. Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?. JGeriatr Psychiatry Neurol 2004, 17(3):137-145.
14. McKeith I., Del Ser T., Spano P., et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000, 356(9247):2031-2036.
15. Hanyu H., Sato T., Hirao K., et al. Differences in clinical course between dementia with Lewy bodies and Alzheimer's disease. Eur J Neurol 2009, 16(2):212-217.
16. Bostrom F., Jonsson L., Minthon L., et al. Patients with dementia with Lewy bodies have more impaired quality of life than patients with Alzheimer disease. Alzheimer Dis Assoc Disord 2007, 21(2):150-154.
17. Zaccai J., McCracken C., Brayne C. Asystematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 2005, 34(6):561-566.
18. Pletnikova O., West N., Lee M.K., et al. A[beta] deposition is associated with enhanced cortical [alpha]-synuclein lesions in Lewy body diseases. Neurobiol Aging 2005, 26(8):1183-1192.
19. Kouhei F., Kensuke S., Kazuhito N., et al. Clinicopathological outline of dementia with Lewy bodies applying the revised criteria: the Hisayama study. Brain Pathol 2008, 18(3):317-325.
20. McKeith I. Dementia with Lewy bodies and Parkinson's disease with dementia: where two worlds collide. Pract Neurol 2007, 7(6):374-382.
21. Burton E.J., Karas G., Paling S.M., et al. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage 2002, 17(2):618-630.
22. Burton E.J., McKeith I.G., Burn D.J., et al. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004, 127(Pt 4):791-800.
23. Beyer M.K., Larsen J.P., Aarsland D. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 2007, 69(8):747-754.
24. Sanchez-Castaneda C., Rene R., Ramirez-Ruiz B., et al. Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia. Mov Disord 2009, 24(12):1740-1746.
25. Whitwell J.L., Weigand S.D., Shiung M.M., et al. Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease. Brain 2007, 130(3):708-719.
26. Hanyu H., Shimizu S., Tanaka Y., et al. MR features of the substantia innominata and therapeutic implications in dementias. Neurobiol Aging 2007, 28(4):548-554.
27. Brenneis C., Wenning G.K., Egger K.E., et al. Basal forebrain atrophy is a distinctive pattern in dementia with Lewy bodies. Neuroreport 2004, 15(11):1711-1714.
28. Cousins D.A., Burton E.J., Burn D., et al. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study. Neurology 2003, 61(9):1191-1195.
29. Barber R., McKeith I., Ballard C., et al. Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. JNeurol Neurosurg Psychiatry 2002, 72(3):406-407.
30. Almeida O.P., Burton E.J., McKeith I., et al. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2003, 16(2):57-63.
31. Barber R., Ballard C., McKeith I.G., et al. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology 2000, 54(6):1304-1309.
32. Barber R., McKeith I.G., Ballard C., et al. Acomparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study. Dement Geriatr Cogn Disord 2001, 12(3):198-205.
33. Tam C.W., Burton E.J., McKeith I.G., et al. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 2005, 64(5):861-865.
34. Barkhof F., Polvikoski T.M., van Straaten E.C., et al. The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology 2007, 69(15):1521-1527.
35. Burton E.J., Barber R., Mukaetova-Ladinska E.B., et al. Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment:a prospective study with pathological verification of diagnosis. Brain 2009, 132(1):195-203.
36. Sabattoli F., Boccardi M., Galluzzi S., et al. Hippocampal shape differences in dementia with Lewy bodies. Neuroimage 2008, 41(3):699-705.
37. Firbank M.J., Blamire A.M., Teodorczuk A., et al. High resolution imaging of the medial temporal lobe in Alzheimer's disease and dementia with Lewy bodies. JAlzheimers Dis 2010, 21(4):1129-1140.
38. O'Brien J.T., Paling S., Barber R., et al. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology 2001, 56(10):1386-1388.
39. Burton E.J., Mukaetova-Ladinska E.B., Perry R.H., et al. Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia. Neurobiol Aging 2011, [Epub ahead of print].
40. Ishii K., Yamaji S., Kitagaki H., et al. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 1999, 53(2):413-416.
41. Lobotesis K., Fenwick J.D., Phipps A., et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001, 56(5):643-649.
42. Minoshima S., Foster N.L., Petrie E.C., et al. Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. JGeriatr Psychiatry Neurol 2002, 15(4):200-209.
43. Middelkoop H.A., van der Flier W.M., Burton E.J., et al. Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI. Neurology 2001, 57(11):2117-2120.
44. Gomez-Tortosa E., Newell K., Irizarry M.C., et al. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology 1999, 53(6):1284-1291.
45. Sanchez-Castaneda C., Rene R., Ramirez-Ruiz B., et al. Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia. Mov Disord 2010, 25(5):615-622.
46. Barber R., Gholkar A., Scheltens P., et al. MRI volumetric correlates of white matter lesions in dementia with Lewy bodies and Alzheimer's disease. Int JGeriatr Psychiatry 2000, 15(10):911-916.
47. Barber R., Scheltens P., Gholkar A., et al. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. JNeurol Neurosurg Psychiatry 1999, 67(1):66-72.
48. Burton E.J., McKeith I.G., Burn D.J., et al. Progression of white matter hyperintensities in Alzheimer disease, dementia with Lewy bodies, and Parkinson disease dementia: a comparison with normal aging. Am J Geriatr Psychiatry 2006, 14(10):842-849.
49. Bozzali M., Falini A., Cercignani M., et al. Brain tissue damage in dementia with Lewy bodies: an invivo diffusion tensor MRI study. Brain 2005, 128(Pt 7):1595-1604.
50. Firbank M.J., Blamire A.M., Krishnan M.S., et al. Diffusion tensor imaging in dementia with Lewy bodies and Alzheimer's disease. Psychiatry Res 2007, 155(2):135-145.
51. Matsui H., Nishinaka K., Oda M., et al. Depression in Parkinson's disease. Diffusion tensor imaging study. JNeurol 2007, 254(9):1170-1173.
52. Firbank M.J., Blamire A.M., Teodorczuk A., et al. Diffusion tensor imaging in Alzheimer's disease and dementia with Lewy bodies. Psychiatry Res 2011, 194(2):176-183.
53. Kiuchi K., Morikawa M., Taoka T., et al. White matter changes in dementia with Lewy bodies and Alzheimer's disease: a tractography-based study. JPsychiatr Res 2011, 45(8):1095-1100.
54. Kantarci K., Avula R., Senjem M.L., et al. Dementia with Lewy bodies and Alzheimer disease: neurodegenerative patterns characterized by DTI. Neurology 2010, 74(22):1814-1821.
55. Watson R., Blamire A.M., O'Brien J.T. Magnetic resonance imaging in Lewy body dementias. Dement Geriatr Cogn Disord 2009, 28(6):493-506.
56. Owen A.M., Doyon J., Dagher A., et al. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 1998, 121(Pt 5):949-965.
57. Thiel A., Hilker R., Kessler J., et al. Activation of basalganglia loops in idiopathic Parkinson's disease:a PET study. JNeural Transm 2003, 110(11):1289-1301.
58. Lewis S.J., Dove A., Robbins T.W., et al. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. JNeurosci 2003, 23(15):6351-6356.
59. Holroyd S., Wooten G.F. Preliminary fMRI evidence of visual system dysfunction in Parkinson's disease patients with visual hallucinations. J Neuropsychiatry Clin Neurosci 2006, 18(3):402-404.
60. Meppelink A.M., de Jong B.M., Renken R., et al. Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations. Brain 2009, 132(11):2980-2993.
61. Ramírez-Ruiz B., Martí M.-J., Tolosa E., et al. Brain response to complex visual stimuli in Parkinson's patients with hallucinations: a functional magnetic resonance imaging study. Mov Disord 2008, 23(16):2335-2343.
62. Stebbins G.T., Goetz C.G., Carrillo M.C., et al. Altered cortical visual processing in PD with hallucinations: an fMRI study. Neurology 2004, 63(8):1409-1416.
63. Sauer J., ffytche D.H., Ballard C., et al. Differences between Alzheimer's disease and dementia with Lewy bodies: an fMRI study of task-related brain activity. Brain 2006, 129(Pt 7):1780-1788.
64. Wood J.S., Firbank M.J., Mosimann U.P., et al. Development of a novel FMRI compatible visual perception prototype battery to test older people with and without dementia. JGeriatr Psychiatry Neurol 2011, 24(2):73-83.
65. Galvin J.E., Price J.L., Yan Z., et al. Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease. Neurology 2011, 76(21):1797-1803.
66. Fong T., Inouye S., Dai W., et al. Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?. Brain Imaging Behav 2010, 5(1):25-35.
67. Shimizu S., Hanyu H., Kanetaka H., et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT. Dement Geriatr Cogn Disord 2005, 20(1):25-30.
68. Kemp P.M., Hoffmann S.A., Tossici-Bolt L., et al. Limitations of the HMPAO SPECT appearances of occipital lobe perfusion in the differential diagnosis of dementia with Lewy bodies. Nucl Med Commun 2007, 28(6):451-456.
69. 123I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease. Eur J Nucl Med Mol Imaging 2006, 33(3):248-253.
70. Tateno M., Kobayashi S., Shirasaka T., et al. Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies. Dement Geriatr Cogn Disord 2008, 26(5):453-457.
71. 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies. Int Psychogeriatr 2008, 20(6):1124-1140.
72. Ishii K., Hosaka K., Mori T., et al. Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies. Ann Nucl Med 2004, 18(5):447-451.
73. Sinha N., Firbank M., O'Brien J.T. Biomarkers in dementia with Lewy bodies: a review. Int J Geriatr Psychiatry 2011, [Epub ahead of print].
74. Colloby S.J., Fenwick J.D., Williams E.D., et al. Acomparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging 2002, 29(5):615-622.
75. Nagahama Y., Okina T., Suzuki N., et al. Neural correlates of psychotic symptoms in dementia with Lewy bodies. Brain 2010, 133(Pt 2):557-567.
76. O'Brien J.T., Firbank M.J., Mosimann U.P., et al. Change in perfusion, hallucinations and fluctuations in consciousness in dementia with Lewy bodies. Psychiatry Res 2005, 139(2):79-88.
77. Mori T., Ikeda M., Fukuhara R., et al. Correlation of visual hallucinations with occipital rCBF changes by donepezil in DLB. Neurology 2006, 66(6):935-937.
78. 99mTc-exametazime SPECT patterns in Alzheimer's disease and dementia with Lewy bodies: utility in differential diagnosis. JGeriatr Psychiatry Neurol 2010, 23(1):54-62.
79. 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology 2000, 55(10):1575-1577.
80. O'Brien J.T., Colloby S., Fenwick J., et al. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Arch Neurol 2004, 61(6):919-925.
81. Marshall V.L., Patterson J., Hadley D.M., et al. Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nucl Med Commun 2006, 27(12):933-937.
82. 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007, 6(4):305-313.
83. Walker Z., Jaros E., Walker R.W., et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. JNeurol Neurosurg Psychiatry 2007, 78(11):1176-1181.
84. 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 2009, 194(1):34-39.
85. Murai T., Muller U., Werheid K., et al. Invivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001, 13(2):222-228.
86. Weintraub D., Newberg A.B., Cary M.S., et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. JNucl Med 2005, 46(2):227-232.
87. Happe S., Baier P.C., Helmschmied K., et al. Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson's disease. JNeurol 2007, 254(8):1037-1043.
88. 123I-FP-CIT SPECT study. Mov Disord 2009, 24(14):2097-2103.
89. Tiraboschi P., Hansen L.A., Alford M., et al. Cholinergic dysfunction in diseases with Lewy bodies. Neurology 2000, 54(2):407-411.
90. Tiraboschi P., Hansen L.A., Alford M., et al. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry 2002, 59(10):946-951.
91. Bohnen N.I., Kaufer D.I., Ivanco L.S., et al. Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an invivo positron emission tomographic study. Arch Neurol 2003, 60(12):1745-1748.
92. Shimada H.M., Hirano S.M., Shinotoh H.M., et al. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 2009, 73(4):273-278.
93. 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia. Neuroimage 2006, 33(2):423-429.
94. 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations. Neuroimage 2008, 40(3):1056-1063.
95. 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer's disease and dementia with Lewy bodies. Am J Geriatr Psychiatry 2010, 18(1):86-90.
96. Okamura N., Funaki Y., Tashiro M., et al. Invivo visualization of donepezil binding in the brain of patients with Alzheimer's disease. Br J Clin Pharmacol 2008, 65(4):472-479.
97. Spiegel J., Mollers M.O., Jost W.H., et al. FP-CIT and MIBG scintigraphy in early Parkinson's disease. Mov Disord 2005, 20(5):552-561.
98. Allan L.M., Ballard C.G., Allen J., et al. Autonomic dysfunction in dementia. JNeurol Neurosurg Psychiatry 2007, 78(7):671-677.
99. Yoshita M., Taki J., Yamada M. Aclinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. JNeurol Neurosurg Psychiatry 2001, 71(5):583-588.
100. Nagayama H., Hamamoto M., Ueda M., et al. Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease. JNeurol Neurosurg Psychiatry 2005, 76(2):249-251.
101. Ballard C., Ziabreva I., Perry R., et al. Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology 2006, 67(11):1931-1934.
102. Gomperts S.N., Rentz D.M., Moran E., et al. Imaging amyloid deposition in Lewy body diseases. Neurology 2008, 71(12):903-910.
103. 11C]PIB positron emission tomography. JNeurol Neurosurg Psychiatry 2008, 79(12):1331-1338.